MacroGenics, Inc. - 1792 Exchange

Rating Overview

MacroGenics, Inc. is High Risk.

Macrogenics is is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. The company embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.

Rating Criteria

Corporate Weaponization Risk Levels
Criteria	Risk Level
Cancellations	High Risk
Discriminatory Philanthropy	Lower Risk
Employment Protection	High Risk

Corporate Weaponization ⓘ

Corporate Governance and Public Policy Risk Levels
Criteria	Risk Level
Advocacy Bias	High Risk
Funding	Lower Risk
Political Actions	No Data

Corporate Governance and Public Policy ⓘ

Rating Criteria Detail

Criteria Risk Level Rationale

Corporate Weaponization

Criteria:

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level:

High

Rationale:

Macrogenics, Inc. was sued by previous employee Kathy Stoner after notifying its employees on October 15, 2021, that it would require each employee to receive a COVID-19 vaccine by December 8, 2021. The company declined to grant Stoner’s request for a religious accommodation exempting her from any vaccine, face covering, or invasive testing requirements, and eventually terminated her employment for non-compliance with its policy. The case was dismissed and closed without prejudice (1). The company promotes divisive sex and gender policies. Its Supplier Code of Conduct requires international vendors to include sexual orientation in their nondiscrimination policy (2).

Criteria:

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level:

Lower

Rationale:

MacroGenics, Inc. does not appear to discriminate against charitable organizations based on views or beliefs (1).

Criteria:

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level:

High

Rationale:

Macrogenics, Inc. appears to prioritize diversity over merit in its leadership composition. From its Corporate Governance Guidelines: “the Nominating Committee shall make efforts to identify directors who can add to the diversity of the Board, considering such factors as age, gender, sexual orientation, and racial or ethnic makeup” (1). The company is an affirmative action employer. “It is the policy of MacroGenics… to take positive affirmative action” (2). The company does not provide viewpoint protections for its employees (3).

Corporate Governance and Public Policy

Criteria:

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level:

High

Rationale:

MacroGenics, Inc. was listed as a amici curiae with the Supreme Court in a series of lawsuits as one of the “FDA’s expert determinations that mifepristone is safe and effective under its approved conditions of use,” adovcating for abortion (1). The company supports ESG within its business practices. From its 2024 Corporate Responsibility Report: “we support ESG (Environmental, Social and Governance) initiatives that are aligned with our Living Values” (2).

Criteria:

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Lower

Rationale:

MacroGenics, Inc. has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria:

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level:

N/A

Rationale:

MacroGenics, Inc. does not operate a PAC or engage in lobbying at this time (1)(2)(3).